Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03530449 · ClinicalTrials.gov registry record
Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module
A clinical trial, sponsored by Heidelberg Engineering.
- Terminated
- Registry status
- 39
- Enrollment target
NCT03530449 is a clinical trial that was terminated before completion, run by Heidelberg Engineering. The registered enrollment target is 39 participants.
The verdict
NCT03530449 was terminated before completion, sponsored by Heidelberg Engineering.
- TERMINATED
- Registry status
- 39 participants
- Enrollment target
Study Summary
Repeatability and Reproducibility of OCTA Image Quality with the Heidelberg Engineering SPECTRALIS
Interventions
- DEVICE Optical Coherence Tomography
- DEVICE OCT Angiography
- DEVICE Color Fundus Photography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2018-04-30 |
| Est. Completion | 2018-09-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03530449
The ClinicalTrials.gov registry entry for NCT03530449 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heidelberg Engineering, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Optical Coherence Tomography is the first listed.
NCT03530449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03530449 about?
NCT03530449 is a clinical study titled "Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module". Repeatability and Reproducibility of OCTA Image Quality with the Heidelberg Engineering SPECTRALIS
What is the current status of trial NCT03530449?
This trial is currently terminated. The enrollment target is 39 participants. The study started on 2018-04-30. Estimated completion is 2018-09-15.
What interventions are being tested in trial NCT03530449?
The interventions under investigation include: Optical Coherence Tomography (DEVICE), OCT Angiography (DEVICE), Color Fundus Photography (DEVICE).
Who is sponsoring clinical trial NCT03530449?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.